Literature DB >> 16750354

Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate.

Kenjiro Koga1, Yoichi Kusawake, Yukako Ito, Nobuyuki Sugioka, Nobuhito Shibata, Kanji Takada.   

Abstract

The aim of this study was to clarify the mechanism by which caprylocaproyl macrogol-8 glyceride (Labrasol) enhances the intestinal absorption of gentamicin sulfate (GM), a drug that has poor permeability but relatively high solubility. We studied the following characteristics: (i) the phase behavior of Labrasol in aqueous solution, (ii) the affinity of GM to Labrasol micelles, and (iii) the interaction between Labrasol and membrane lipids. We measured the critical micelle concentration of Labrasol in aqueous solution to be approximately 0.01%. The average diameters of Labrasol micelles in 2% and 25% solutions were approximately 10 nm and 20 nm, respectively, indicating that micelles increase in size with increasing Labrasol concentration. Although GM dissolved in 5% Labrasol solution was dialyzable, GM dissolved in either 25% or 50% Labrasol solutions was not, suggesting that GM exists in the hydrophilic region of the Labrasol micelle or in the high affinity region of the micelle surface where GM is retained. In membrane permeability experiments and electrophysiological studies conducted with rat ileum, only 25% Labrasol solution enhanced GM permeability, but did not remarkably affect membrane resistance. Furthermore, Labrasol increased membrane lipid fluidity as determined by fluorescence anisotropy in porcine intestinal brush border membrane liposomes. These results suggest that high concentrations of Labrasol solution enhance membrane permeability of GM via a transcellular rather than a paracellular route. We propose the following mechanism: Labrasol micelles grow when the concentration of Labrasol exceeds 20%, at which point GM shows high affinity for the hydrophilic region of the micelles. Since Labrasol micelles increase membrane lipid fluidity, the membrane permeability of GM is concomitantly enhanced.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750354     DOI: 10.1016/j.ejpb.2006.03.011

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  16 in total

1.  Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.

Authors:  Naveen Chella; Bhaskar Daravath; Dinesh Kumar; Rama Rao Tadikonda
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

2.  Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design.

Authors:  Naveen K Bejugam; Helen J Parish; Gita N Shankar
Journal:  AAPS PharmSciTech       Date:  2009-12-01       Impact factor: 3.246

3.  Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.

Authors:  Brijesh Shah; Dignesh Khunt; Manju Misra; Harish Padh
Journal:  Pharm Res       Date:  2018-01-02       Impact factor: 4.200

4.  Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation.

Authors:  Bashar M Altaani; Ammar M Almaaytah; Suha Dadou; Khouloud Alkhamis; Mousa H Daradka; Wael Hananeh
Journal:  Pharm Res       Date:  2020-04-06       Impact factor: 4.200

5.  Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems.

Authors:  Tanmoy Sadhukha; Buddhadev Layek; Swayam Prabha
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

6.  Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system.

Authors:  Anna Kruczynski; Isabelle Vandenberghe; Arnaud Pillon; Sabrina Pesnel; Liliane Goetsch; Jean-Marc Barret; Yves Guminski; Alain Le Pape; Thierry Imbert; Christian Bailly; Nicolas Guilbaud
Journal:  Invest New Drugs       Date:  2009-09-24       Impact factor: 3.850

7.  Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L.

Authors:  David M Ribnicky; Peter Kuhn; Alexander Poulev; Sithes Logendra; Aamir Zuberi; William T Cefalu; Ilya Raskin
Journal:  Int J Pharm       Date:  2008-11-25       Impact factor: 5.875

8.  Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies.

Authors:  Saeed Alqahtani; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  AAPS J       Date:  2013-04-10       Impact factor: 4.009

9.  Hypoglycemic activity of a novel anthocyanin-rich formulation from lowbush blueberry, Vaccinium angustifolium Aiton.

Authors:  Mary H Grace; David M Ribnicky; Peter Kuhn; Alexander Poulev; Sithes Logendra; Gad G Yousef; Ilya Raskin; Mary Ann Lila
Journal:  Phytomedicine       Date:  2009-03-20       Impact factor: 5.340

10.  Dynamic modulation of spleen germinal center reactions by gut bacteria during Plasmodium infection.

Authors:  Rabindra K Mandal; Joshua E Denny; Ruth Namazzi; Robert O Opoka; Dibyadyuti Datta; Chandy C John; Nathan W Schmidt
Journal:  Cell Rep       Date:  2021-05-11       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.